What is it about?

Medication delivery through the skin via patches or gels has the purported advantage of avoiding metabolism in the liver which can result in reduced bioavailability and creation of side effect-inducing metabolites. This article reviews the data on transdermal delivery of the antimuscarinic medication oxybutynin.

Featured Image

Why is it important?

We review the most up to date information regarding the mechanism of action, efficacy, cost, and availability of transdermal delivery systems for oxybutynin.

Read the Original

This page is a summary of: An update on the use of transdermal oxybutynin in the management of overactive bladder disorder, Therapeutic Advances in Urology, January 2016, SAGE Publications,
DOI: 10.1177/1756287215626312.
You can read the full text:

Read

Contributors

The following have contributed to this page